Table 1.
Symbol | 24 h IL-11 vs control | 7 day IL-11 vs control |
---|---|---|
Immune response | ||
Serpina3n | 10.9 | 16.7 |
Hp | * | 12.9 |
Dmbt1 | 6.4 | 8.1† |
Lcn2 | * | 7.1 |
Ly6d | * | 5.8 |
Serpina3g | 3.1 | 6.6 |
Spp1 | 4.3 | 5.3 |
C4a | * | 5.0 |
Ifitm1 | 2.9 | 5.0 |
Pigr | 2.5 | 4.3 |
Serpina3m | * | 3.7 |
Cxcl17 | * | 3.4 |
Ifitm3 | 2.6 | 3.4 |
Il33 | 2.4† | 3.4† |
Cxcl13 | * | 3.2 |
Osmr | 1.8 | 2.8 |
Ly6a | * | 2.4 |
Cf1 | * | 2.3 |
Cxcl14 | * | 2.2 |
Serpinb1a | 2.2 | 2.2 |
Serpinf2 | * | 2.1 |
Irf1 | 2.1 | * |
Icam1 | * | 1.8 |
Tnfrsf12a | * | 1.7 |
Myd88 | 1.9 | 1.7 |
Proliferation/apoptosis/differentiation | ||
Reg3b | 64.3 | 146.7 |
Reg1 | 24.7 | 63.2 |
Reg3g | 13.4 | 39.9 |
Wfdc2 | * | 6.0† |
Reg3a | 1.5 | 5.5 |
Igfbp4 | 2.1 | 3.7† |
Bmp1 | * | 3.3 |
Gadd45g | 2.6 | 2.5 |
Gsdmc1 | 1.9 | 2.1 |
Grem1 | 2.0 | 2.0 |
Bcl3 | 1.6 | 1.9 |
Muc1 | 1.9 | * |
Sfrp1 | * | 1.8 |
Reg3d | * | 1.8 |
Klf5 | * | 1.7 |
Mki67 | * | 1.6 |
Shh | * | 1.5 |
Gdf9 | * | −6.1 |
Blm | −4.0 | −5.6 |
Mist1 | * | −2.3 |
Bmpr1b | * | −2.1 |
Tob1 | * | −2.0 |
Egf | * | −2.0 |
Transport | ||
Aqp5 | 2.1 | 5.2† |
Kcnk1 | * † | 1.7† |
Kcng4 | 1.7 | * |
Slc38a5 | * | −3.9 |
Slc26a9 | * † | −2.7† |
Kcnj16 | * † | −2.6† |
Kcnk5 | * | −2.5 |
Kcnf1 | * † | −2.3† |
Kcnj15 | * † | −2.0† |
Aqp4 | −2.0 | * |
Atp2c1 | * | −1.7 |
Slc5a8 | * † | −1.7† |
Slc16a5 | * | −1.6 |
Slc25a12 | * | −1.6 |
Slc26a6 | * † | −1.5† |
Slc24a3 | 1.5† | * † |
Protein degradation | ||
Timp1 | 5.4† | 6.9† |
Mmp3 | 1.8 | 2.1† |
Adam28 | 1.9 | 2.0 |
Adamdec1 | * | 1.8 |
Efemp2 | 1.6 | 1.7 |
Mmp23 | * | 1.7 |
Mmp13 | * | 1.6 |
Try10 | * | −33.1 |
Try4 | * | −21.1 |
Amy2 | * | −22.3 |
Cpm | −1.9 | −2.3 |
Endocrine | ||
Chgb | * | 1.9 |
Car11 | * | 1.5 |
Gper | −2.8 | −5.2 |
Sstr2 | * | −2.2 |
Cckbr | −1.8† | −2.0† |
Ddc | −1.6 | −1.8 |
Signal transduction | ||
Socs3 | 5.2 | 6.6 |
Stat3 | * | 2.0 |
Socs2 | * | 1.8 |
Jak3 | 1.8 | 1.7 |
Junb | 1.7 | 1.6 |
Il-11ra1 | * | −1.6 |
Listed are transcripts of interest that had a fold changed 1.5 or greater and an adjusted p value of 0.05 or less for either 24 h or 7 days treatment with IL-11. Transcripts are clustered into six distinct functional groups; immune response, signal transduction, proliferation/apoptosis/differentiation, transport, protein degradation and endocrine.
Indicates expression at this time point not significantly altered by IL-11 expression.
Indicates transcriptional regulation confirmed by quantitative PCR analysis.